SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934

         Date of Report (Date of earliest event reported): May 26, 2000



                             PSS WORLD MEDICAL, INC.
             (Exact name of registrant as specified in its charter)




            Florida                  0-23832                     59-2280364
         -------------            -------------              ------------------
         (State or other           (Commission                 (IRS Employer
         jurisdiction of           File Number)              Identification No.)
         incorporation)



             4345 Southpoint Boulevard, Jacksonville, Florida 32216
          (Address, including zip code, of principal executive offices)

                                 (904) 332-3000
              (Registrant's telephone number, including area code)







Item 4.  Changes in and Disagreements With Accountants on Accounting and
Financial Disclosure.


(1) (i) Ernst & Young LLP has  previously  been  engaged to audit the  financial
statements of Gulf South Medical  Supply,  Inc.  ("Gulf  South"),  a significant
subsidiary of PSS World Medical,  Inc. ("PSS"), and on whom Arthur Andersen LLP,
the principal  accountants of PSS had expressed reliance on their report. On May
26, 2000, PSS dismissed Ernst & Young LLP as the accountants for Gulf South, and
from such date will instead rely on the audit opinion of Arthur  Andersen LLP as
auditor of PSS, as well as the auditor of Gulf South.

         (ii) The  report  of Ernst & Young  LLP on the  consolidated  financial
statements  for Gulf South as of and for the years ended  December  31, 1997 and
1996 did not contain an adverse  opinion or a  disclaimer  of  opinion,  nor was
qualified or modified as to uncertainty, audit scope, or accounting principles.

         (iii) The decision to change accountants for Gulf South was approved by
the audit  committee  of the Board of  Directors of PSS, as well as the Board of
Directors of PSS.

         (iv) In  connection  with its audit of Gulf  South for the years  ended
December 31, 1997 and 1996, there were no  disagreements  with Ernst & Young LLP
on any  matter  of  accounting  principles  or  practices,  financial  statement
disclosure, or auditing scope or procedure,  which disagreements if not resolved
to the  satisfaction of Ernst & Young LLP would have caused Ernst & Young LLP to
make  reference  thereto in their report on the  financial  statements  for such
years.  However,  the previously reported financial statements of Gulf South for
the years ended December 31, 1997 and 1996 were recently restated in a filing on
Form  10-K/A for the year ended April 2, 1999 as noted in  paragraph  (2) below.
These  restated  financial  statements of Gulf South were not audited by Ernst &
Young LLP and Ernst & Young LLP  might not agree  with such  restated  financial
statements if asked to concur.

         (v)      Ernst & Young LLP did not advise the Company of any of events
reportable under Rule 304(a)(1)(v).

(2)  Arthur  Andersen  LLP,  principal  accountant  of the  Company's  financial
statements, has independently audited the financial statements of Gulf South and
issued  their  opinion on the  financial  statements  of Gulf South.  During the
registrant's  previous two fiscal years,  the Company has consulted  with Arthur
Andersen LLP  regarding  (i) the  application  of  accounting  principles to the
acquisition  by merger  of Gulf  South and (ii) the  restatement  of  previously
reported  financial  statements of Gulf South.  In each case the views of Arthur
Andersen LLP regarding those matters are as described in the restatements of the
financial statements of the Company as reported and in footnotes 4, 18 and 22 to
the  Company's  most  recent Form 10-K/A for the fiscal year ended April 2, 1999
filed on May 25, 2000.


                                   SIGNATURES

                  Pursuant to the requirements of the Securities Exchange Act of
1934,  the  registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                                                     PSS WORLD MEDICAL, INC.
                                                          (Registrant)



                             By: /s/ David A. Smith

                             David A. Smith, Executive Vice President
                             and Chief Financial Officer

Date:  May 31, 2000